menu
    • menu

    Company profile for Entos Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We develop next generation nucleic acid-based therapies using our proprietary Fusogenix drug delivery system. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. The technology is applicable to a wide range of nucleic acid medicines. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of...
    We develop next generation nucleic acid-based therapies using our proprietary Fusogenix drug delivery system. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. The technology is applicable to a wide range of nucleic acid medicines. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. The technology is applicable to a wide range of therapeutic types including gene therapy, mRNA, miRNA, RNAi and CRISPR.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Entos PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 2220, 3210 Merryfield Row San Diego, CA 92121
    Telephone
    Telephone
    1-780-862-7445
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.entospharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/entospharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Circio, Entos Collaborate on Circular RNA Delivery Research
    Circio, Entos Collaborate on Circular RNA Delivery Research

    03 Apr 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/circio-entos-enter-research-collaboration-focused-on-circular-rna-delivery/

    CONTRACTPHARMA
    03 Apr 2025
    Share Share
    Entos Secures $198.5M Canada, Alberta Deal For Manufacturing
    Entos Secures $198.5M Canada, Alberta Deal For Manufacturing

    11 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250311006058/en

    BUSINESSWIRE
    11 Mar 2025
    Share Share
    Entos Pharma Awarded $4M for Congenital Lipodystrophy
    Entos Pharma Awarded $4M for Congenital Lipodystrophy

    05 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250205385688/en

    BUSINESSWIRE
    05 Feb 2025
    Share Share
    Aegis Life And Entos Complete Phase 1 Enrollment For Covid Vaccine
    Aegis Life And Entos Complete Phase 1 Enrollment For Covid Vaccine

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919753686/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Entos Pharma Doses First Participant In COVID-19 Booster Trial
    Entos Pharma Doses First Participant In COVID-19 Booster Trial

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240806540138/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    Entos Pharmaceuticals Receives Approval From Health Canada To Begin Clinical
    Entos Pharmaceuticals Receives Approval From Health Canada To Begin Clinical

    10 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240610041728/en

    BUSINESSWIRE
    10 Jun 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search